Hydroxychloroquine
Hydroxychloroquine, sold under the brand name Plaquenil among others, is a drug used to prevent and treat malaria. It can also treat rheumatoid arthritis, lupus, and porphyria cutanea tarda.[1]
Common side effects may include vomiting, headache, changes in vision, and muscle weakness.
Hydroxychloroquine was approved for medical use in the United States in 1955.[2]
Clinical trials showed that Hydroxychloroquine does prevent or treat coronavirus disease 2019 (COVID‑19), [3]. Its use was later found to have contributed to 16,990 deaths in six countries during spring 2020 due to cardiovascular toxicity.[4]
References[change | change source]
- ↑ "Hydroxychloroquine Sulfate Monograph for Professionals". The American Society of Health-System Pharmacists. 20 March 2020. Archived from the original on 20 March 2020. Retrieved 20 March 2020.
- ↑ World Health Organization model list of essential medicines: 21st list 2019. World Health Organization. 2019. hdl:10665/325771.
- ↑ "Chloroquine or Hydroxychloroquine". COVID-19 Treatment Guidelines. National Institutes of Health. Archived from the original on 2020-08-28. Retrieved 2021-02-14.
- ↑ "Antimalarial Drug Cost Lives During Pandemic". Medscape UK. Retrieved 2024-02-12.
